Znanstveni rad - Izvorni znanstveni rad
Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina
Croatian Medical Journal, 60 (2019), 3; 212-220. https://doi.org/10.3325/cmj.2019.60.212

Ašić, Adna; Salazar, Ramona; Storm, Niels; Doğan, Serkan; Höppner, Wolfgang; Marjanović, Damir; Primorac, Dragan

Citirajte ovaj rad

Ašić, A., Salazar, R., Storm, N., Doğan, S., Höppner, W., Marjanović, D. i Primorac, D. (2019). Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina. Croatian Medical Journal, 60. (3), 212-220. doi: 10.3325/cmj.2019.60.212

Ašić, Adna, et al. "Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina." Croatian Medical Journal, vol. 60, br. 3, 2019, str. 212-220. https://doi.org/10.3325/cmj.2019.60.212

Ašić, Adna, Ramona Salazar, Niels Storm, Serkan Doğan, Wolfgang Höppner, Damir Marjanović i Dragan Primorac. "Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina." Croatian Medical Journal 60, br. 3 (2019): 212-220. https://doi.org/10.3325/cmj.2019.60.212

Ašić, A., et al. (2019) 'Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina', Croatian Medical Journal, 60(3), str. 212-220. doi: 10.3325/cmj.2019.60.212

Ašić A, Salazar R, Storm N, Doğan S, Höppner W, Marjanović D, i sur.. Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina. Croatian Medical Journal [Internet]. 2019. [pristupljeno 18.05.2022.];60(3):212-220. doi: 10.3325/cmj.2019.60.212

A. Ašić, et al., "Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina", Croatian Medical Journal, vol. 60, br. 3, str. 212-220, 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:188436. [Citirano: 18.05.2022.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.